APA

Chin H., Horng C., Liu Y., Lu C., Su C., Chen P., Chiu H., Tsai F., Shieh P. & Yang J. (20180829). Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. : Oncology reports.

Chicago

Chin Hsien-Kuo, Horng Chi-Ting, Liu Yi-Shan, Lu Chi-Cheng, Su Chen-Ying, Chen Pei-Syuan, Chiu Hong-Yi, Tsai Fuu-Jen, Shieh Po-Chuen and Yang Jai-Sing. 20180829. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. : Oncology reports.

Harvard

Chin H., Horng C., Liu Y., Lu C., Su C., Chen P., Chiu H., Tsai F., Shieh P. and Yang J. (20180829). Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. : Oncology reports.

MLA

Chin Hsien-Kuo, Horng Chi-Ting, Liu Yi-Shan, Lu Chi-Cheng, Su Chen-Ying, Chen Pei-Syuan, Chiu Hong-Yi, Tsai Fuu-Jen, Shieh Po-Chuen and Yang Jai-Sing. Kaempferol inhibits angiogenic ability by targeting VEGF receptor-2 and downregulating the PI3K/AKT, MEK and ERK pathways in VEGF-stimulated human umbilical vein endothelial cells. : Oncology reports. 20180829.